Conn. High Court Would Allow Drug Design Defect, Warnings Claims, U.S. Judge Says

NEW HAVEN, Conn. - A Connecticut federal judge on May 24 predicted that the state Supreme Court would allow design defect and warnings defect claims in prescription drug injury cases (Lynn Gardner Moss, et al. v. Wyeth, Inc., et al., No. 3:04-1511, D. Conn.). Subscribers may view the opinion available within the full update.

Access this news story on®